Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1990 Aug;80(8):954–958. doi: 10.2105/ajph.80.8.954

The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT).

J K Ockene 1, L H Kuller 1, K H Svendsen 1, E Meilahn 1
PMCID: PMC1404774  PMID: 2368857

Abstract

The impact of smoking cessation on coronary heart disease (CHD) and lung cancer was assessed after 10.5 years of follow-up in the 12,866 men in the Multiple Risk Factor Intervention Trial (MRFIT). Those men who died of lung cancer (n = 119) were either cigarette smokers at entry or ex-smokers; no lung cancer deaths occurred among the 1,859 men who reported never smoking cigarettes. The risk of lung cancer for smokers, adjusted for selected baseline variables using a Cox proportional hazards model, increased as the number of cigarettes smoked increased (B = 0.0203, SE = 0.0076). There was not the same graded response for CHD among smokers at entry. The risk of CHD death was greater among smokers than nonsmokers (RR = 1.57) (B = -0.0034, S.E. = 0.0048). After one year of cessation, the relative risk of dying of CHD for the quitters as compared to non-quitters (RR = 0.63) was significantly lower even after adjusting for baseline differences and changes in other risk factors. The relative risk for smokers who quit for at least the first three years of the trial was even lower compared to non-quitters (RR = 0.38). However, the relative risk for lung cancer for quitters versus non-quitters was close to 1 both for quitters at 12 months and at three years. These data support the benefits of cessation in relation to CHD and are consistent with other epidemiologic studies which suggest that the lag time for a beneficial effect of smoking cessation on lung cancer may be as long as 20 years.

Full text

PDF
954

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benfari R. C. The multiple risk factor intervention trial (MRFIT). III. The model for intervention. Prev Med. 1981 Jul;10(4):426–442. doi: 10.1016/0091-7435(81)90059-1. [DOI] [PubMed] [Google Scholar]
  2. Breslow N. Covariance analysis of censored survival data. Biometrics. 1974 Mar;30(1):89–99. [PubMed] [Google Scholar]
  3. Butts W. C., Kueheman M., Widdowson G. M. Automated method for determining serum thiocyanate, to distinguish smokers from nonsmokers. Clin Chem. 1974 Oct;20(10):1344–1348. [PubMed] [Google Scholar]
  4. Cutler J. A., Neaton J. D., Hulley S. B., Kuller L., Paul O., Stamler J. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials. Prev Med. 1985 May;14(3):293–311. doi: 10.1016/0091-7435(85)90058-1. [DOI] [PubMed] [Google Scholar]
  5. Doll R., Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J. 1976 Dec 25;2(6051):1525–1536. doi: 10.1136/bmj.2.6051.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Holme I., Hjermann I., Helgeland A., Leren P. The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men. Prev Med. 1985 May;14(3):279–292. doi: 10.1016/0091-7435(85)90057-x. [DOI] [PubMed] [Google Scholar]
  7. Hughes G. H., Hymowitz N., Ockene J. K., Simon N., Vogt T. M. The multiple risk factor intervention trial (MRFIT). V. Intervention on smoking. Prev Med. 1981 Jul;10(4):476–500. doi: 10.1016/0091-7435(81)90061-x. [DOI] [PubMed] [Google Scholar]
  8. Kornitzer M., De Backer G., Dramaix M., Kittel F., Thilly C., Graffar M., Vuylsteek K. Belgian heart disease prevention project: incidence and mortality results. Lancet. 1983 May 14;1(8333):1066–1070. doi: 10.1016/s0140-6736(83)91908-6. [DOI] [PubMed] [Google Scholar]
  9. Kornitzer M., Rose G. WHO European Collaborative Trial of multifactorial prevention of coronary heart disease. Prev Med. 1985 May;14(3):272–278. doi: 10.1016/0091-7435(85)90056-8. [DOI] [PubMed] [Google Scholar]
  10. Lubin J. H., Blot W. J., Berrino F., Flamant R., Gillis C. R., Kunze M., Schmahl D., Visco G. Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer. 1984 May 15;33(5):569–576. doi: 10.1002/ijc.2910330504. [DOI] [PubMed] [Google Scholar]
  11. Rogot E., Murray J. L. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep. 1980 May-Jun;95(3):213–222. [PMC free article] [PubMed] [Google Scholar]
  12. Rose G. European collaborative trial of multifactorial prevention of coronary heart disease. Lancet. 1987 Mar 21;1(8534):685–685. doi: 10.1016/s0140-6736(87)90446-6. [DOI] [PubMed] [Google Scholar]
  13. Rose G., Hamilton P. J., Colwell L., Shipley M. J. A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health. 1982 Jun;36(2):102–108. doi: 10.1136/jech.36.2.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sherwin R., Kaelber C. T., Kezdi P., Kjelsberg M. O., Thomas H. E., Jr The multiple risk factor intervention trial (MRFIT) II. The development of the protocol. Prev Med. 1981 Jul;10(4):402–425. doi: 10.1016/0091-7435(81)90058-x. [DOI] [PubMed] [Google Scholar]
  15. Walker W. J., Brin B. N. U.S. lung cancer mortality and declining cigarette tobacco consumption. J Clin Epidemiol. 1988;41(2):179–185. doi: 10.1016/0895-4356(88)90092-3. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES